Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$1.12 - $1.49 $36 - $49
-33 Reduced 0.01%
535,789 $637,000
Q1 2023

May 12, 2023

BUY
$1.19 - $2.19 $699 - $1,287
588 Added 0.11%
535,822 $803,000
Q4 2022

Feb 10, 2023

SELL
$1.07 - $1.34 $25,123 - $31,463
-23,480 Reduced 4.2%
535,234 $647,000
Q3 2022

Nov 14, 2022

SELL
$1.09 - $1.67 $5.1 Million - $7.82 Million
-4,680,285 Reduced 89.34%
558,714 $609,000
Q2 2022

Aug 11, 2022

BUY
$1.13 - $3.69 $507,849 - $1.66 Million
449,424 Added 9.38%
5,238,999 $7.81 Million
Q1 2022

May 13, 2022

BUY
$2.85 - $3.73 $119,734 - $156,704
42,012 Added 0.88%
4,789,575 $15.8 Million
Q4 2021

Feb 11, 2022

BUY
$3.24 - $5.18 $1.6 Million - $2.57 Million
495,218 Added 11.65%
4,747,563 $16 Million
Q3 2021

Nov 12, 2021

SELL
$3.94 - $5.84 $2.12 Million - $3.14 Million
-537,879 Reduced 11.23%
4,252,345 $21.7 Million
Q2 2021

Aug 13, 2021

BUY
$4.26 - $6.5 $3.01 Million - $4.59 Million
706,185 Added 17.29%
4,790,224 $21 Million
Q1 2021

May 13, 2021

SELL
$5.03 - $8.8 $2.72 Million - $4.76 Million
-541,081 Reduced 11.7%
4,084,039 $25.4 Million
Q4 2020

Feb 10, 2021

BUY
$4.04 - $5.31 $6.74 Million - $8.86 Million
1,667,609 Added 56.39%
4,625,120 $22.6 Million
Q3 2020

Nov 12, 2020

BUY
$3.64 - $7.76 $2.44 Million - $5.21 Million
671,482 Added 29.37%
2,957,511 $12.5 Million
Q2 2020

Aug 14, 2020

BUY
$4.78 - $8.26 $477,177 - $824,579
99,828 Added 4.57%
2,286,029 $15.8 Million
Q1 2020

May 15, 2020

BUY
$4.0 - $21.53 $2.31 Million - $12.4 Million
576,799 Added 35.84%
2,186,201 $8.75 Million
Q4 2019

Feb 14, 2020

SELL
$13.94 - $24.12 $16.2 Million - $28.1 Million
-1,165,591 Reduced 42.0%
1,609,402 $34.7 Million
Q3 2019

Nov 14, 2019

BUY
$13.89 - $23.16 $257,270 - $428,969
18,522 Added 0.67%
2,774,993 $42.1 Million
Q2 2019

Aug 14, 2019

BUY
$16.27 - $20.51 $1.63 Million - $2.05 Million
100,159 Added 3.77%
2,756,471 $0
Q1 2019

May 15, 2019

SELL
$12.61 - $22.33 $2.99 Million - $5.3 Million
-237,170 Reduced 8.2%
2,656,312 $55.1 Million
Q4 2018

Feb 14, 2019

SELL
$12.41 - $22.98 $10.1 Million - $18.6 Million
-810,750 Reduced 21.89%
2,893,482 $39.4 Million
Q3 2018

Nov 14, 2018

BUY
$2.45 - $16.27 $9.07 Million - $60.3 Million
3,703,706 Added 704126.62%
3,704,232 $60.3 Million
Q2 2018

Aug 14, 2018

BUY
$2.68 - $3.48 $61 - $80
23 Added 4.57%
526 $2,000
Q4 2017

Feb 14, 2018

SELL
$3.06 - $4.09 $37,806 - $50,531
-12,355 Reduced 96.09%
503 $2,000
Q3 2017

Nov 14, 2017

BUY
$3.03 - $3.72 $4,235 - $5,200
1,398 Added 12.2%
12,858 $45,000
Q2 2017

Aug 14, 2017

BUY
N/A
11,460
11,460 $46,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $214M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.